Advanced search
Publication Cover
Current Medical Research and Opinion Volume 31, 2015 - Issue 10
Submit an article Journal homepage
1,262
Views
12
CrossRef citations to date
0
Altmetric
Diabetes

Dipeptidyl peptidase-4 inhibitors in triple oral therapy regimens in patients with type 2 diabetes mellitus

Anthony H. BarnettHeart of England NHS Foundation Trust and University of Birmingham, Birmingham, UK, Nantes, FranceCorrespondence[email protected]
,
Bernard CharbonnelCentre Hospitalier, Universitaire de Nantes, Nantes, France
,
Robert G. MosesIllawarra Diabetes Service, South East Sydney & Illawarra Area Health Service, Wollongong, Australia
&
Sanjay KalraBharti Hospital and Bharti Research Institute of Diabetes and Endocrinology, Kamal, India
Pages 1919-1931 | Accepted 05 Aug 2015, Published online: 20 Aug 2015

Citations (12)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

André J. Scheen. (2017) Dapagliflozin and saxagliptin tablets for adults with type 2 diabetes. Expert Review of Clinical Pharmacology 10:12, pages 1303-1316.
Read now
André J. Scheen. (2017) Pharmacokinetic drug evaluation of saxagliptin plus dapagliflozin for the treatment of type 2 diabetes. Expert Opinion on Drug Metabolism & Toxicology 13:5, pages 583-592.
Read now
André J. Scheen. (2017) Pharmacotherapy of ‘treatment resistant’ type 2 diabetes. Expert Opinion on Pharmacotherapy 18:5, pages 503-515.
Read now
André J. Scheen. (2016) DPP-4 inhibitor plus SGLT-2 inhibitor as combination therapy for type 2 diabetes: from rationale to clinical aspects. Expert Opinion on Drug Metabolism & Toxicology 12:12, pages 1407-1417.
Read now
André J. Scheen. (2016) Investigational insulin secretagogues for type 2 diabetes. Expert Opinion on Investigational Drugs 25:4, pages 405-422.
Read now

Articles from other publishers (7)

Yongfa Sun, Lili Song, Yong Zhang, Hongjun Wang & Xiao Dong. (2020) Adipose stem cells from type 2 diabetic mice exhibit therapeutic potential in wound healing. Stem Cell Research & Therapy 11:1.
Crossref
M. Krempf. (2019) Les inhibiteurs des SGLT2 : traitement anti diabétiques et/ou de la prévention cardiovasculaire et/ou protection rénale ? Place au débat. Archives of Cardiovascular Diseases Supplements 11, pages S23-S29.
Crossref
A.J. Scheen. (2019) Solutions thérapeutiques pour un patient diabétique de type 2 mal contrôlé sous une combinaison metformine plus gliptine. Médecine des Maladies Métaboliques 13:3, pages 272-279.
Crossref
Yonghyun Kim, Eun Seok Kang, Hak Chul Jang, Dong Jun Kim, Taekeun Oh, Eun Sook Kim, Nan-Hee Kim, Kyung Mook Choi, Sung-Rae Kim, JiYoung You, Se-Jin Kim & Moon-Kyu Lee. (2019) Teneligliptin versus sitagliptin in Korean patients with type 2 diabetes inadequately controlled with metformin and glimepiride: A randomized, double-blind, non-inferiority trial. Diabetes, Obesity and Metabolism 21:3, pages 631-639.
Crossref
Wen Xu, Yiming Mu, Jiajun Zhao, Dalong Zhu, Qiuhe Ji, Zhiguang Zhou, Bin Yao, Anhua Mao, Samuel S. Engel, Bin Zhao, Yan Bi, Longyi Zeng, Xingwu Ran, Juming Lu, Linong Ji, Wenying Yang, Weiping Jia & Jianping Weng. (2017) Efficacy and safety of metformin and sitagliptin based triple antihyperglycemic therapy (STRATEGY): a multicenter, randomized, controlled, non-inferiority clinical trial. Science China Life Sciences 60:3, pages 225-238.
Crossref
Silvio E. Inzucchi & David R. Matthews. 2017. Textbook of Diabetes. Textbook of Diabetes 471 492 .
Thomas Wilke, Sabrina Mueller, Antje Groth, Bjoern Berg, Niklas Hammar, Katherine Tsai, Andreas Fuchs, Stephanie Stephens & Ulf Maywald. (2016) Effectiveness of sulphonylureas in the therapy of diabetes mellitus type 2 patients: an observational cohort study. Journal of Diabetes & Metabolic Disorders 15:1.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.